Abstract
Background
The purpose of this study was to explore the demographics, multimodality therapeutic outcomes*** and prognostic factors in sinonasal rhabdomyosarcoma (SNRMS).
Methods
We conducted a retrospective analysis of 40 patients who underwent treatment of SNRMS from March 2007 to March 2018. The Kaplan–Meier method and the log-rank test were used to assess survival rates. The Cox regression model was used for multivariate survival analysis.
Results
In total, 25 males and 15 females were included in the study; the median age was 33 years (range, 2–67 years). All patients underwent surgical resection, and surgery prior to or after adjuvant therapy (chemotherapy and radiotherapy) was performed in 91.4% of the patients. The overall 1-, 3- and 5-year survival rates were 77.0%, 46.5% and 46.5%, respectively, during a mean follow-up time of 27.9 (range, 2–128) months in all patients. The log-rank test showed Intergroup Rhabdomyosarcoma Study (IRS) group and infiltration of the skull base influenced overall survival (p = 0.001; p = 0.022). Advanced IRS stage, lymph node metastasis and tumor size ≥ 5 cm were also associated with an unfavorable outcome on overall survival (p = 0.01; p = 0.035; p = 0.02). The results of multivariate regression analysis showed patients with IRS group I were associated with better prognosis outcome on overall survival.
Conclusion
Patients with SNRMS have poor 5-year overall survival, and IRS group is the independent prognostic factor for overall survival.
Similar content being viewed by others
References
Callender TA, Weber RS, Janjan N, Benjamin R, Zaher M, Wolf P, El-Naggar A (1995) Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg 112:252–257. https://doi.org/10.1016/S0194-59989570246-6
Casey DL, Wolden SL (2018) Rhabdomyosarcoma of the Head and Neck: a Multimodal Approach. J Neurol Surg B Skull Base 79:58–64. https://doi.org/10.1055/s-0037-1617450
Choi PJ, Iwanaga J, Tubbs RS, Yilmaz E (2018) Surgical interventions for advanced parameningeal rhabdomyosarcoma of children and adolescents. Cureus 10:e2045. https://doi.org/10.7759/cureus.2045
Daya H, Chan HS, Sirkin W, Forte V (2000) Pediatric rhabdomyosarcoma of the head and neck: is there a place for surgical management? Arch Otolaryngol Head Neck Surg 126:468–472
Ferrari A et al (2003) Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 98:571–580. https://doi.org/10.1002/cncr.11550
Fyrmpas G, Wurm J, Athanassiadou F, Papageorgiou T, Beck JD, Iro H, Constantinidis J (2009) Management of paediatric sinonasal rhabdomyosarcoma. J Laryngol Otol 123:990–996. https://doi.org/10.1017/S0022215109005337
Gerber NK et al (2013) Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols. Int J Radiat Oncol Biol Phys 86:58–63. https://doi.org/10.1016/j.ijrobp.2012.12.016
Haussler SM, Stromberger C, Olze H, Seifert G, Knopke S, Bottcher A (2018) Head and neck rhabdomyosarcoma in children: a 20-year retrospective study at a tertiary referral center. J Cancer Res Clin Oncol 144:371–379. https://doi.org/10.1007/s00432-017-2544-x
Healy GB, Upton J, Black PM, Ferraro N (1991) The role of surgery in rhabdomyosarcoma of the head and neck in children. Arch Otolaryngol Head Neck Surg 117:1185–1188
Hicks J, Flaitz C (2002) Rhabdomyosarcoma of the head and neck in children. Oral Oncol 38:450–459
Ognjanovic S, Linabery AM, Charbonneau B, Ross JA (2009) Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975–2005. Cancer 115:4218–4226. https://doi.org/10.1002/cncr.24465
Orbach D et al (2017) Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies. Head Neck 39:24–31. https://doi.org/10.1002/hed.24547
Raney RB et al (2001) The Intergroup Rhabdomyosarcoma Study Group (IRSG): major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols. Sarcoma 5:9–15. https://doi.org/10.1080/13577140120048890
Rekhi B, Singhvi T (2014) Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas. APMIS 122:1144–1152. https://doi.org/10.1111/apm.12272
Sanghvi S, Misra P, Patel NR, Kalyoussef E, Baredes S, Eloy JA (2013) Incidence trends and long-term survival analysis of sinonasal rhabdomyosarcoma. Am J Otolaryngol 34:682–689. https://doi.org/10.1016/j.amjoto.2013.04.012
Siddiqui SH et al (2019) Clinicopathologic traits and prognostic factors associated with pediatric sinonasal rhabdomyosarcoma. Int Forum Allergy Rhinol 9:363–369. https://doi.org/10.1002/alr.22267
Skapek SX et al (2013) PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children’s oncology group report. Pediatr Blood Cancer 60:1411–1417. https://doi.org/10.1002/pbc.24532
Stepan K et al (2017) Outcomes in adult sinonasal rhabdomyosarcoma. Otolaryngol Head Neck Surg 157:135–141. https://doi.org/10.1177/0194599817696287
Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A (2009) Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2600 patients. J Clin Oncol 27:3391–3397. https://doi.org/10.1200/jco.2008.19.7483
Tsai JW et al (2019) The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases. Histopathology 74:933–943. https://doi.org/10.1111/his.13819
Turner JH, Richmon JD (2011) Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data. Otolaryngol Head Neck Surg 145:967–973. https://doi.org/10.1177/0194599811417063
Unsal AA, Chung SY, Unsal AB, Baredes S, Eloy JA (2017) A population-based analysis of survival for sinonasal rhabdomyosarcoma. Otolaryngol Head Neck Surg 157:142–149. https://doi.org/10.1177/0194599817696292
Wharam MD Jr (1997) Rhabdomyosarcoma of Parameningeal Sites. Semin Radiat Oncol 7:212–216. https://doi.org/10.1053/SRAO00700212
Wu Y, Li C, Zhong Y, Guo W, Ren G (2014) Head and neck rhabdomyosarcoma in adults. J Craniofac Surg 25:922–925. https://doi.org/10.1097/SCS.0000000000000704
Wurm J, Constantinidis J, Grabenbauer GG, Iro H (2005) Rhabdomyosarcomas of the nose and paranasal sinuses: treatment results in 15 cases. Otolaryngol Head Neck Surg 133:42–50. https://doi.org/10.1016/j.otohns.2005.03.023
Funding
This work was financially supported by the National Natural Science Foundation of China (No. 81870703).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, W., Lu, H. & Wang, D. Therapeutic outcome and prognostic factors in sinonasal rhabdomyosarcoma: a single-institution case series. J Cancer Res Clin Oncol 145, 2793–2802 (2019). https://doi.org/10.1007/s00432-019-03009-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-019-03009-8